Artery Therapeutics, Inc.
PrivateLast Round
Grant
Jul 12, 2022
Total Funding Raised
$3.88M
Company Overview
Artery Therapeutics, Inc. is a biotechnology company that develops proprietary peptide therapeutics for neurodegenerative and metabolic diseases, including Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artery Therapeutics, Inc. Comparables
Compare Artery Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allyx Therapeutics, Inc. | 76% | |
| Epoch Biotech | 75% | |
| Halia Therapeutics | 71% |
Artery Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 12, 2022 | ||||
| Seed | Dec 1, 2021 | ||||
| Grant | Sep 21, 2021 | ||||
| Grant | Jun 1, 2019 |
Artery Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2022
Received grant funding from Alzheimer's Association National Capital Area Chapter.
- Dec 1, 2021
$2M raised in Seed round.
Artery Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Artery Therapeutics, Inc.'s valuation, stock price, and market status.
Is Artery Therapeutics, Inc. a public or private company?
Artery Therapeutics, Inc. is a private company.
What is the current stock price of Artery Therapeutics, Inc.?
Artery Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Artery Therapeutics, Inc. worth (valuation)?
Valuation information for Artery Therapeutics, Inc. is not publicly available.
Can I buy Artery Therapeutics, Inc. stock?
Artery Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Artery Therapeutics, Inc.'s last funding round?
Artery Therapeutics, Inc.'s most recent funding round was Grant on July 12, 2022.
Who are the main investors in Artery Therapeutics, Inc.?
Key investors in Artery Therapeutics, Inc. include NIH RADx, National Institute on Aging.
Will Artery Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Artery Therapeutics, Inc..
How can I track Artery Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Artery Therapeutics, Inc.'s secondary market activity and sign up for updates.